Innate Pharma SA financial data

Symbol
IPHA on Nasdaq, IPHYF on OTC
Location
Marseille
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 30 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 83,830,336 shares 4.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets €111,059,000 EUR -36.6%